Radioactive injection targets Hard-to-Treat cancers in early trial
NCT ID NCT07274852
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a radioactive drug called lutetium BL-ARC001 in 22 people with advanced lung, breast, head and neck, or other solid tumors that have stopped responding to standard therapies. The drug is given by IV infusion over a 6-week cycle. The main goals are to check safety, find the best dose, and get a first look at whether it can shrink tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lutetium [177Lu]-BL-ARC001 injection
- What this could lead to
- If successful, this could lead to a new targeted radiation therapy for several advanced solid tumors that have not responded to standard treatments.
- What could go wrong
- This is a very early Phase I trial with only 22 participants, so safety and dosing are still being determined. The treatment may not shrink tumors or could cause significant side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Digital peer support: a new weapon against cancer treatment anxiety?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?